{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:32:15Z","timestamp":1791415935774,"version":"4.3.3"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T00:00:00Z","timestamp":1281398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000797","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T19:26:22Z","timestamp":1281468382000},"page":"e797","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Prophylactic Efficacy of TcVac2 against Trypanosoma cruzi in Mice"],"prefix":"10.1371","volume":"4","author":[{"given":"Shivali","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha Jain","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control.","volume":"22","author":"CJ Schofield","year":"2006","journal-title":"Trends Parasitol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: A Latin American health problem becoming a world health problem.","volume":"115","author":"GA Schmunis","year":"2010","journal-title":"Acta Trop"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/IAI.65.7.2548-2554.1997","article-title":"Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of <italic>Trypanosoma cruzi<\/italic> trypomastigotes reduces infection in mice.","volume":"65","author":"G Franchin","year":"1997","journal-title":"Infect Immun"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-4758(99)01581-1","article-title":"The targets of the lytic antibody response against <italic>Trypanosoma cruzi<\/italic>.","volume":"16","author":"GM Krautz","year":"2000","journal-title":"Parasitol Today"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","article-title":"Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in <italic>Trypanosoma cruzi<\/italic> infection.","volume":"70","author":"N Garg","year":"2002","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-3024.1999.00201.x","article-title":"Comparison of antibody and protective immune responses against <italic>Trypanosoma cruzi<\/italic> infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.","volume":"21","author":"VL Pereira-Chioccola","year":"1999","journal-title":"Parasite Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-3024.2000.00260.x","article-title":"Chagasic patients develop a type 1 immune response to <italic>Trypanosoma cruzi<\/italic> trans-sialidase.","volume":"22","author":"M Ribeirao","year":"2000","journal-title":"Parasite Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.158.7.3293","article-title":"Delivery by <italic>Trypanosoma cruzi<\/italic> of proteins into the MHC class I antigen processing and presentation pathway.","volume":"158","author":"N Garg","year":"1997","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/IAI.64.4.1093-1099.1996","article-title":"A recombinant protein based on the <italic>Trypanosoma cruzi<\/italic> metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection.","volume":"64","author":"FR Santori","year":"1996","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1128\/IAI.68.9.4986-4991.2000","article-title":"DNA-Based immunization with <italic>trypanosoma cruzi<\/italic> complement regulatory protein elicits complement lytic antibodies and confers protection against <italic>trypanosoma cruzi<\/italic> infection.","volume":"68","author":"P Sepulveda","year":"2000","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/IAI.69.10.6558-6563.2001","article-title":"DNA immunization with <italic>Trypanosoma cruzi<\/italic> HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.","volume":"69","author":"L Planelles","year":"2001","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1128\/IAI.70.9.5065-5074.2002","article-title":"Cruzipain induces both mucosal and systemic protection against <italic>Trypanosoma cruzi<\/italic> in mice.","volume":"70","author":"AR Schnapp","year":"2002","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00144-08","article-title":"Previously unrecognized vaccine candidates control <italic>Trypanosoma cruzi<\/italic> infection and immunopathology in mice.","volume":"15","author":"V Bhatia","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/14760584.4.6.867","article-title":"Current status and future prospects for a vaccine against American trypanosomiasis.","volume":"4","author":"V Bhatia","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease.","volume":"115","author":"JA Marin-Neto","year":"2007","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/S0074-02762009000900037","article-title":"Swimming against the current: genetic vaccination against <italic>Trypanosoma cruzi<\/italic> infection in mice.","volume":"104","author":"MM Rodrigues","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0035-9203(85)90061-6","article-title":"Immunization of marmosets with <italic>Trypanosoma cruzi<\/italic> cell surface glycoprotein (GP90).","volume":"79","author":"MT Scott","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0020-7519(96)00099-9","article-title":"<italic>Trypanosoma cruzi:<\/italic> the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).","volume":"26","author":"D Laderach","year":"1996","journal-title":"Int J Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0264-410X(03)00541-3","article-title":"Use of a purified <italic>Trypanosoma cruzi<\/italic> antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.","volume":"22","author":"FM Frank","year":"2003","journal-title":"Vaccine"},{"key":"ref20","first-page":"1407","article-title":"American trypanosomiasis and perspectives on vaccine development.","author":"V Bhatia","year":"2009"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/IAI.01163-07","article-title":"Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against <italic>Trypanosoma cruzi<\/italic>.","volume":"76","author":"SI Cazorla","year":"2008","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1128\/IAI.73.11.7356-7365.2005","article-title":"Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control <italic>Trypanosoma cruzi<\/italic> infection.","volume":"73","author":"Y Miyahira","year":"2005","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/hum.2006.17.898","article-title":"Long-term protective immunity induced against <italic>Trypanosoma cruzi<\/italic> infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase.","volume":"17","author":"AV Machado","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1128\/IAI.01459-08","article-title":"Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, <italic>Trypanosoma cruzi,<\/italic> elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.","volume":"77","author":"BC de Alencar","year":"2009","journal-title":"Infect Immun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.0818-9641.2002.01136.x","article-title":"A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to <italic>Trypanosoma cruzi<\/italic> infection in a highly susceptible mouse strain.","volume":"81","author":"JR Vasconcelos","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/IAI.72.11.6245-6254.2004","article-title":"Utility of <italic>Trypanosoma cruzi<\/italic> sequence database for the identification of potential vaccine candidates: In silico and in vitro screening.","volume":"72","author":"V Bhatia","year":"2004","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges.","volume":"175","author":"JJ Donnelly","year":"2005","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-0556-2-17","article-title":"DNA vaccines: designing strategies against parasitic infections.","volume":"2","author":"C Ivory","year":"2004","journal-title":"Genet Vaccines Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2008.11.032","article-title":"Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.","volume":"54","author":"J Scharpe","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2008.10.002","article-title":"Protective effect of a RSV subunit vaccine candidate G1F\/M2 was enhanced by a HSP70-Like protein in mice.","volume":"377","author":"R Zeng","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria.","volume":"199","author":"AC Moore","year":"2004","journal-title":"Immunol Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.vaccine.2005.08.048","article-title":"Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.","volume":"24","author":"SC Gilbert","year":"2006","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.182.5.1423","article-title":"Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.","volume":"182","author":"A Campos-Neto","year":"1995","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1112631","article-title":"The genome sequence of <italic>Trypanosoma cruzi,<\/italic> etiologic agent of Chagas disease.","volume":"309","author":"NM El-Sayed","year":"2005","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.","volume":"65","author":"T Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0925-4439(03)00060-7","article-title":"Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in <italic>Trypanosoma cruzi<\/italic>-infected murine hearts: implications in chagasic myocarditis development.","volume":"1638","author":"N Garg","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1042\/BJ20040356","article-title":"Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways.","volume":"381","author":"N Garg","year":"2004","journal-title":"Biochem J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis.","volume":"7","author":"H McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.7770767","article-title":"IL-12 at the crossroads [news] [see comments].","volume":"268","author":"SS Hall","year":"1995","journal-title":"Science"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/clinids\/21.6.1439","article-title":"Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases.","volume":"21","author":"R Lin","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Pt 6","key":"ref41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/icb.1989.50","article-title":"IgG subclasses responsible for immune clearance in mice infected with <italic>Trypanosoma cruzi<\/italic>.","volume":"67","author":"CI Brodskyn","year":"1989","journal-title":"Immunol Cell Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-3024.1993.tb00603.x","article-title":"Host genetics and resistance to acute <italic>Trypanosoma cruzi<\/italic> infection in mice. I. Antibody isotype profiles.","volume":"15","author":"MR Powell","year":"1993","journal-title":"Parasite Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0264-410X(97)00277-6","article-title":"Immunization with a plasmid DNA containing the gene of trans-sialidase reduces <italic>Trypanosoma cruzi<\/italic> infection in mice.","volume":"16","author":"F Costa","year":"1998","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.vetimm.2008.03.003","article-title":"IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct <italic>Trypanosoma cruzi<\/italic> strains.","volume":"124","author":"PM Guedes","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1590\/S0001-37652005000400009","article-title":"An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress.","volume":"77","author":"MA Zacks","year":"2005","journal-title":"An Acad Bras Cienc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/eji.1830221006","article-title":"The microbicidal activity of interferon-gamma-treated macrophages against <italic>Trypanosoma cruzi<\/italic> involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.","volume":"22","author":"RT Gazzinelli","year":"1992","journal-title":"Eur J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000237653","article-title":"Immunological control of <italic>Trypanosoma cruzi<\/italic> infection and pathogenesis of Chagas&apos; disease.","volume":"114","author":"Z Brener","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1128\/IAI.61.12.5129-5133.1993","article-title":"Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with <italic>Trypanosoma cruzi<\/italic> or <italic>Trypanosoma brucei<\/italic>.","volume":"61","author":"ME Rottenberg","year":"1993","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.4049\/jimmunol.140.12.4342","article-title":"In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental <italic>Trypanosoma cruzi<\/italic> infections.","volume":"140","author":"SG Reed","year":"1988","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/cimm.1996.0132","article-title":"Antigen-specific IL-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to <italic>Trypanosoma cruzi<\/italic> infection.","volume":"170","author":"LC Barbosa de Oliveira","year":"1996","journal-title":"Cell Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.146.10.3626","article-title":"Endogenous IFN-gamma is required for resistance to acute <italic>Trypanosoma cruzi<\/italic> infection in mice.","volume":"146","author":"F Torrico","year":"1991","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/IAI.68.1.197-204.2000","article-title":"Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.","volume":"68","author":"DF Hoft","year":"2000","journal-title":"Infect Immun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.1993.48.637","article-title":"Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes.","volume":"48","author":"DD Reis","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1590\/S0074-02761999000700042","article-title":"The role of the immune response on the development of severe clinical forms of human Chagas disease.","volume":"94","author":"R Correa-Oliveira","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1286-4579(00)00388-9","article-title":"Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with <italic>Trypanosoma cruzi.<\/italic>","volume":"2","author":"A Talvani","year":"2000","journal-title":"Microbes Infect"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T18:59:20Z","timestamp":1685732360000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000797"}},"subtitle":[],"editor":[{"given":"Ricardo T.","family":"Gazzinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,10]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000797","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,10]]}}}